CIK 0001582554 · Non-accelerated filer<br>Smaller reporting company
Matinas BioPharma Holdings, Inc.
Sign in to watch- Ticker
- MTNB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463011414
- Phone
- 908-484-8805
- Business address
- 1545 ROUTE 206 SOUTH, SUITE 302, BEDMINSTER, NJ, 07921
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- EFFECT Other Notice of Effectiveness
- 8-K Event Results of operations · Regulation FD disclosure
- S-3 Offering Registration Statement
- 10-K Report Annual Report
- 8-K Event Executive or director change · Regulation FD disclosure
- SC 13D Stake Beneficial Ownership Report
- 4 Option exercise 10% owner acquired 1,369,169 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- CERTNYS Other Certification by the New York Stock Exchange
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 24 of 29 · 576 filings